DEDRA ALEXANDER: Open Payments
NPI 1033694955 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,727 in 154 payments from 16 companies in 2025. Trend: 2023 $281 · 2024 $646 · 2025 $2,727
Food & beverage: $2,715Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $511 |
| Otsuka America Pharmaceutical, Inc. | 34 | $482 |
| Alkermes, Inc. | 25 | $338 |
| Neurocrine BioSciences, Inc. | 13 | $316 |
| Teva Pharmaceuticals USA, Inc. | 13 | $195 |
| Vanda Pharmaceuticals Inc. | 11 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $157 |
| Axsome Therapeutics, Inc. | 10 | $141 |
| Janssen Pharmaceuticals, Inc | 6 | $127 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
Products named: VRAYLAR, INGREZZA, ARISTADA, REXULTI, ABILIFY ASIMTUFII, FANAPT, CAPLYTA, Auvelity.
Industry payments across LA — which companies pay providers there.
